On Jun. 1, 2021, AquaBounty Technologies announced the successful completion of the first commercial scale harvest of its genetically engineered (GE) Atlantic salmon at the Albany, Indiana Farm; the regulatory approval of the Company’s GE Atlantic salmon by Brazil’s National Biosafety Technical Commission (CTNBio); and the addition of Gail Sharps Myers to AquaBounty’s Board of Directors.

CTNBio assessed AquaBounty’s application to ensure it met the relevant standards and regulatory requirements and concluded that the sale and consumption of AquaBounty’s GE salmon is safe for the environment and human health. CTNBio’s approval joins that of the U.S. Food and Drug Administration and Health Canada, making AquaBounty the first and only company in the world to have its GE Atlantic salmon approved in these three major markets.

AquaBounty Technologies is a leader in aquaculture leveraging decades of technology expertise to deliver game changing solutions that solve global problems, while improving efficiency, sustainability and profitability. AquaBounty provides fresh Atlantic salmon to nearby markets by raising its fish in carefully monitored land-based fish farms through a safe, secure and sustainable process. The Company’s land-based Recirculating Aquaculture System (“RAS”) farms, located in Indiana, United States and Prince Edward Island, Canada, are close to key consumption markets and are designed to prevent disease and to include multiple levels of fish containment to protect wild fish populations. AquaBounty is raising nutritious salmon that is free of antibiotics and other contaminants and provides a solution resulting in a reduced carbon footprint and no risk of pollution to marine ecosystems as compared to traditional sea-cage farming.